Author | John A. Kosteva, MD | OncLive

Author | John A. Kosteva, MD


Dr. Kosteva on Single-Agent Versus Combination Immunotherapy in NSCLC

July 05, 2018


John A. Kosteva, MD, clinical assistant professor of medicine, University of Pennsylvania School of Medicine, Abramson Cancer Center, discusses the adoption of immunotherapy into the treatment paradigm for patients with non–small cell lung cancer (NSCLC).